バルビタール

Barbital

HCID 2294CAS 57-44-3

基本情報

標準SMILES
CCC1(CC)C(=O)NC(=O)NC1=O
InChIKey
FTOAOBMCPZCFFF-UHFFFAOYSA-N
分子式
C8H12N2O3
平均分子量
184.19 g/mol
単同位体質量
184.08479224

概要

5,5-diethylbarbituric acid is a member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by two ethyl groups. Formerly used as a hypnotic (sleeping aid). It has a role as a drug allergen.

名称と識別子

優先名称
Barbital
IUPAC
5,5-diethyl-1,3-diazinane-2,4,6-trione
現地名
バルビタール
英語名
BARBITAL
分子式
C8H12N2O3
分子量
184.19

名称と別名

barbitalBarbitone5,5-Diethylbarbituric acid57-44-3DiethylmalonylureaEthylbarbitalDiemalDEBADTXSID50226435,5-diethylpyrimidine-2,4,6(1H,3H,5H)-trione5WZ53ENE2PNSC-31352
名称をさらに表示
5,5-ジエチルヘキサヒドロピリミジン-2,4,6-トリオン5,5-ジエチルバルビツル酸バルビトン5,5-ジエチル-ピリミジン-2,4,6(1H,3H,5H)-トリオン5,5-ジエチルピリミジン-2,4,6(1H,3H,5H)-トリオンジエチルマロニル尿素ベロナール5,5-ジエチル-2,4,6(1H,3H,5H)-ピリミジントリオンべロナール(バルビタール)バルビタール (JP17)バルビタール5,5-ジエチル-1,3-ジアジナン-2,4,6-トリオンジエチルバルビツル酸5,5-ジエチルバルビツール酸Barbitone acidDIETHYLBARBITURIC ACID5,5-diethyl-1,3-diazinane-2,4,6-trioneMalona
CHEBI:31252DTXCID802643RefChem:388818200-331-2VeronalVesperalMalonalUronal

データベース識別子

CAS
57-44-3
PubChem CID
2294
DTXSID
DTXSID5022643
ChEMBL
CHEMBL444
ChEBI
CHEBI:31252
UNII
5WZ53ENE2P
EC Number
200-331-2
Nikkaji
J2.326D

物性

構造計算による物性

XLogP
0.6
極性表面積
75.3 Ų
水素結合供与体数
2
水素結合受容体数
3
回転可能結合数
2
重原子数
13

実験および物理化学的性質

Drugs · 5 件

DEA NFLIS-Drug Category -> Depressants and Tranquilizers

DEA Schedule IV Controlled Substance -> Depressants

Pharmaceuticals -> Barbiturates

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

SpringerMaterials PropertiesCrystal structure
LogP0.71
Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Dissociation Constants8.14 (at 15 °C)
Collision Cross Section145.28 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
188 · 188-192°C
沸点
318.14 °C · 318.14°C (rough estimate)
比重(密度)
1.22 · 1.2200
屈折率
1.42 · 1.4200 (estimate)
闪点
11 °C · 11 °C
貯蔵温度
2 · 2-8°C

化学的性質

化学的特性White crystals or powder; bitter taste; odorless. Stable in air. Soluble in hot water, alcohol, ether, acetone, and ethyl acetate.

安全と法規制

GHS分類

GHS Classification · 4 件

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 40 reports by companies from 1 notifications to the ECHA C&L Inventory.

危険有害性情報

Regulatory Information · 3 件

DEA schedule IV controlled substance

Status: Active Update: 26-05-2016 https://echa.europa.eu/registration-dossier/-/registered-dossier/17765

Barbitone: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5,5-diethyl-: Human health tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

安全データ

wgk
3
rtecs
CQ3500000
ridadr
UN 1230 3/PG 2
毒性
LDLo orl-cat: 280 mg/kg PHREA7 19,472,39
risk_code
22-39/23/24/25-23/24/25-11-63-40-20
hazard_code
Xn,T,F

化学と産業

薬理情報

ATC Code · 2 件

N - Nervous system

QN - Nervous system

MeSH Pharmacological Classification · 2 件

Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.

Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here.

用途と製造

Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan
応用分野 · 5 件

解説バルビタール白色の針状晶.無臭で,わずかに苦味を呈す.融点188~192 ℃.水,熱水,エタノールに溶解する.バルビツル酸誘導体の長時間作用型睡眠薬で,中枢神経系に対する抑制作用がある.習慣性を有し,0.8~1.0 g を2~3か月連続使用すると禁断症状を伴う慢性中毒となる.そのほか,吐き気,頭痛,無気力感などの副作用もある.ベロナール,バルビトーン,マロナールなどの商品名で市販されている.エチル基がフェニル基に置き換わったフェノバルビタールは,バルビタールに比べて4倍の催眠作用をもつ.

用途バルビツール酸誘導体です。 中枢神経系に作用し、特に脳幹網様体賦活系 に対する抑制作用を示します。作用時間は長 時間です。

用途バルビツール酸誘導体です。 中枢神経系に作用し、特に脳幹網様体賦活系 に対する抑制作用を示します。作用時間は長 時間です。

説明Barbital is an analytical reference material that is categorized as a barbiturate. It acts as an agonist at GABAA receptors to induce central nervous system depression. Formulations containing barbital have been used as a sedative to treat insomnia and seizures in human and veterinary medicine. Barbital is regulated as a Schedule IV compound in the United States. This product is intended for research and forensic applications.

使用Prototype of the barbiturate hypnotics.

調製方法

純化方法Crystallise barbital from water or EtOH and dry it in a vacuum over P2O5. [Beilstein 24 III/IV 1901.]

上流・下流製品情報

補足説明

定義ChEBI: A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by two ethyl groups. Formerly used as a hypnotic (sleeping aid).

関連反応

7 件

関連ノート

読み込み中…